It is a matter of debate whether cancer-specific or all-cause mortality should be the principal measure to evaluate cancer screening efficacy.

About cancer screenings and saving lives: measuring the effects of cancer screening programs through meta-analyses-A comment to the meta-analysis "Estimated Lifetime Gained With Cancer Screening Tests" by Bretthauer et al. (2023)

Mantovani, William;
2024-01-01

Abstract

It is a matter of debate whether cancer-specific or all-cause mortality should be the principal measure to evaluate cancer screening efficacy.
2024
all-cause mortality
cancer
cancer-specific mortality
follow-up time
lifetime gained
screening efficacy
screening programs
secondary prevention
File in questo prodotto:
File Dimensione Formato  
fpubh-12-1376377.pdf

accesso aperto

Licenza: Creative commons
Dimensione 133.17 kB
Formato Adobe PDF
133.17 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1127786
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact